12:38 PM EDT, 06/24/2022 (MT Newswires) -- Valneva (VALN) said Friday that it has secured marketing authorization in Europe from the European Commission for its inactivated whole-virus VLA2001 COVID-19 vaccine for use as primary vaccination in people aged between 18 and 50 years.
美国东部时间2022年6月24日下午12：38(MT Newswres)--Valneva(VALN)周五表示，它已获得欧盟委员会对其灭活全病毒VLA2001新冠肺炎疫苗在欧洲的营销授权，用于18至50岁人群的初级疫苗接种。
The authorization will cover all 28 European Union member countries, as well as Iceland, Liechtenstein and Norway.
这项授权将覆盖所有28个欧盟成员国，以及冰岛、列支敦士登和挪威。
Valneva shares were down about 11% in recent trading.
Valneva的股价在最近的交易中下跌了约11%。
Price: 28.00, Change: -3.44, Percent Change: -10.96
价格：28.00，变化：-3.44，变化百分比：-10.96